Medical Robotics & Devices
Surgical robots, interventional devices, rehabilitation exoskeletons, and AI-powered imaging instruments — the hardware side of healthcare transformation. This page focuses on physical devices and robotic systems, distinct from pharmaceuticals, diagnostics, and drug discovery.
Automation Progress
The largest and most mature segment. Intuitive Surgical's da Vinci platform dominates globally, but new entrants — Medtronic's Hugo, Johnson & Johnson's Ottava, and Chinese systems like Toumai and Kangduo — are intensifying competition. The market is expanding beyond urology into general surgery, thoracic, and head & neck procedures.
da Vinci receives FDA clearance — the modern era begins
Intuitive Surgical's da Vinci Surgical System received FDA clearance for general laparoscopic surgery, becoming the first commercially successful surgical robot. It defined the paradigm: 3D HD vision, wristed instruments, tremor filtering, and a seated console for the surgeon.
da Vinci 5 launched — force feedback arrives
Intuitive unveiled the da Vinci 5, the first da Vinci system with haptic (force) feedback, giving surgeons a sense of touch. It also features 10,000× the computing power of the previous generation, enabling real-time AI tissue analytics and 3D instrument tracking. Over 9,300 da Vinci systems are now installed worldwide.
Medtronic's Hugo RAS receives CE mark for urological surgery
Medtronic's Hugo™ robotic-assisted surgery system received CE mark approval in Europe for urological procedures, marking the first major competitor to da Vinci in the soft-tissue surgery space from a top-tier medtech company. Hugo features modular, independent arms and an open-console design.
Chinese surgical robots gain NMPA approvals and scale domestically
MicroPort's Toumai and Kangduo's KangDuo-SurgAssist have received NMPA approval and are being deployed across major Chinese hospitals. Shanghai-based Edge Medical's "MP1000" orthopedic robot also gained traction. China aims to reduce reliance on imported surgical platforms through its "Made in China 2025" medical device push.
First fully autonomous robotic suturing demonstrated in vivo
Johns Hopkins researchers demonstrated the Smart Tissue Autonomous Robot (STAR) performing laparoscopic suturing on live porcine tissue without human intervention, matching or exceeding expert surgeon performance on key metrics. Published in Science Robotics — a milestone toward autonomous surgery.
Bone is rigid and measurable — making orthopedics a natural fit for robotic precision. Joint replacement and spine surgery robots guide drill paths, saw cuts, and screw placements with sub-millimeter accuracy, reducing revision rates and improving implant alignment.
Stryker's Mako surpasses 1 million joint replacements
The Mako SmartRobotics™ system, originally designed for partial knee replacement, has expanded to total knee and total hip arthroplasty. By 2025, Stryker reported over 1 million procedures completed worldwide. The system uses a preoperative CT-based 3D plan and provides real-time haptic boundaries during bone preparation.
Globus Medical's ExcelsiusGPS dominates spine navigation
The ExcelsiusGPS system combines robotic arm guidance with full navigation for pedicle screw placement in spine surgery. Following Globus Medical's merger with NuVasive (completed 2023), the combined company reported over 100,000 procedures and rapid international expansion. Screw placement accuracy exceeds 98%.
TINAVI and HURWA expand China's domestic orthopedic robotics
Beijing-based TINAVI Medical's TiRobot has been deployed in 200+ Chinese hospitals for spine and trauma surgery. HURWA (Shanghai) also gained NMPA approval for its joint replacement robot. China's orthopedic robot installations grew over 60% year-over-year in 2024.
Robotics is entering the catheterization lab and bronchoscopy suite. Flexible robotic catheters and navigating platforms allow cardiologists and pulmonologists to reach deeper into the body with greater precision and less radiation exposure. This domain bridges imaging, navigation, and miniaturized mechanics.
Auris Health (J&J) Monarch platform for robotic bronchoscopy
Acquired by Johnson & Johnson for $3.4B in 2019, the Monarch platform uses a flexible robotic endoscope with real-time navigation to reach peripheral lung nodules for biopsy — areas difficult to access with standard bronchoscopy. Over 50,000 procedures have been performed. It represents a new paradigm: robot-as-navigator inside the body.
Siemens Healthineers' Corindus for robotic vascular intervention
The Corindus CorPath GRX system enables robotic-assisted percutaneous coronary intervention (PCI), allowing cardiologists to control guidewires and stent delivery from a radiation-shielded cockpit. Siemens Healthineers reported expanded use in complex PCI and peripheral vascular interventions, with reduced operator radiation exposure by up to 95%.
Stereotaxis Genesis robotic magnetic navigation system — zero fluoroscopy EP ablation
Stereotaxis's Genesis system uses external magnets to steer flexible catheters inside the heart for electrophysiology (EP) ablation procedures. Centers reported achieving zero-fluoroscopy procedures — entirely eliminating X-ray radiation during cardiac ablation — a major safety milestone.
Wearable robotic exoskeletons and rehabilitation robots are restoring mobility for stroke, spinal cord injury, and orthopedic patients. The technology is transitioning from research labs to clinical wards and even home use, driven by aging populations and labor shortages in physical therapy.
Ekso Bionics & ReWalk: FDA-cleared exoskeletons reach clinical adoption
EksoNR (Ekso Bionics) and ReWalk's systems are FDA-cleared for stroke and spinal cord injury rehabilitation. Ekso reported installations in 400+ rehabilitation centers globally. ReWalk's personal-use exoskeleton allows paraplegic users to walk independently at home — a landmark for medical device autonomy.
China's UBTECH and Fourier Intelligence target rehab robotics at scale
Fourier Intelligence's ExoMotus M4, a lower-limb rehabilitation exoskeleton, is deployed in 2,000+ hospitals and rehabilitation centers in China. UBTECH launched Walker S Slim for assisted rehabilitation. China's rehab robot market grew to $1.2B in 2024, driven by a 300M+ aging population and national rehabilitation infrastructure expansion.
Brain-computer interface (BCI) integrated with exoskeletons for paralyzed patients
Multiple groups — including BrainGate (Brown/Stanford), Onward Medical (Switzerland), and Tsinghua University — demonstrated closed-loop BCI-exoskeleton systems where paralyzed patients use thought-decoded signals to control robotic limbs. Onward's ARC-EX system received breakthrough device designation from the FDA for spinal cord injury rehabilitation.
AI is being embedded directly into medical imaging hardware — colonoscopes that detect polyps in real time, capsule endoscopes with onboard classifiers, and surgical microscopes with overlay analytics. Unlike software-only AI, these are physical devices with integrated intelligence.
Medtronic GI Genius: AI-assisted colonoscopy becomes standard of care
Medtronic's GI Genius module, based on Cosmo AI's technology, provides real-time AI polyp detection during colonoscopy. FDA-cleared and CE-marked, it has been shown to increase adenoma detection rates (ADR) by 14% in randomized controlled trials. Deployed in thousands of endoscopy suites globally — one of the first AI medical devices to achieve mass adoption.
Olympus EVIS X1 with AI — next-gen endoscope platform integrates real-time AI
Olympus's latest endoscopy platform, EVIS X1, integrates AI-powered image enhancement, lesion detection, and characterization directly into the endoscope processor. The system provides real-time depth estimation and tissue characterization, moving AI from an add-on module to a core device capability.
FDA surpasses 1,000 AI/ML-enabled medical device clearances
By early 2025, the FDA has cleared over 1,000 AI/ML-enabled medical devices — the majority in radiology (CT, MRI, X-ray), but increasingly in cardiology, ophthalmology, and gastroenterology. This regulatory momentum signals that AI-embedded devices have moved from novelty to mainstream medical infrastructure.
The next frontier: robots small enough to navigate blood vessels, deliver drugs to tumors, and perform microsurgery at the cellular level. Magnetically guided microrobots and DNA-origami nanomachines are transitioning from lab demonstrations to early animal trials.
ETH Zurich's magnetically guided microrobot navigates porcine blood vessels
Researchers at ETH Zurich demonstrated a sub-millimeter magnetic soft robot that could be navigated through the blood vessels of a living pig using external magnetic fields. The robot delivered a therapeutic payload to a target site — a key step toward clinical micro-robotic intervention.
Targeted cancer therapy via nanorobots in animal models
Multiple groups — including teams at Chinese Academy of Sciences, Caltech, and Max Planck — demonstrated nanorobot-based targeted drug delivery to tumors in mouse models, achieving 5–10× higher drug concentration at tumor sites compared to free drug. Clinical translation remains 5–10 years away, but the proof of concept is established.